- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06756230
Downhill Walking in IPF
Effects of Downhill Walking in Pulmonary Rehabilitation for Patients With Idiopathic Pulmonary Fibrosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Esra Pehlivan, Associate Professor
- Phone Number: 02164189616
- Email: fztesrakambur@yahoo.com
Study Contact Backup
- Name: Nisanur TUTUŞ
- Email: nisanurrtutus@gmail.com
Study Locations
-
-
Üsküdar
-
İstanbul, Üsküdar, Turkey, 34668
- Recruiting
- Saglik Bilimleri Universitesi
-
Contact:
- Esra Pehlivan, Associate Professor
- Phone Number: 02164189616
- Email: fztesrakambur@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having a diagnosis of IPF according to the clinical diagnostic criteria of the American Thoracic Society and/or the European Respiratory Society (ATS-ERS).
- Being between the ages of 18 and 75.
- Being able to walk on a treadmill.
- Having the ability to cooperate.
- No change in current medication in the last month.
- Not participating in a structured activity program for at least six months.
- Accepting the purpose and method of this study voluntarily and give informed consent for the study.
Exclusion Criteria:
- Presence of physical or mental impairment that prevents informed consent or compliance with the protocol.
- Inability to attend more than 20% of pulmonary rehabilitation sessions.
- Presence of major cardiovascular disease (coronary artery disease, uncontrolled hypertension, arrhythmias, or heart failure).
- Presence of existing orthopedic and neuromuscular exercise limitations.
- Acute exacerbation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Downhill Walking PR Group
A standard pulmonary rehabilitation (PR) exercise program will be implemented.
Downhill treadmill walking will be included during walking sessions.
|
8 weeks, 2 sessions per week, Aerobic training will be provided as treadmill walking. It will be performed either downhill or on a flat treadmill, depending on the group. Warm-up and stretching exercises Resistance exercises will be performed with a load equivalent to 50% of 1 maximum repetition. 10 repetitions will be performed in sets, one set in each session. Based on the differences in the general condition of the patients, different workloads and modifications will be used when creating an exercise program for each patient. Resistance exercises will focus on both upper and lower extremity muscles.
Treadmill exercise will be applied for 30 minutes in the target heart rate range of 60-80% intensity.
The target heart rate method will be used to determine the exercise intensity.
Blood pressure, heart rate and Borg Perceived Exertion Scale scores will be monitored during the exercises.
Downhill walking training will continue with a constant -10% incline.
|
|
Active Comparator: Standard PR group
A standard pulmonary rehabilitation (PR) exercise program will be implemented.
Walking will be performed on a treadmill without incline.
|
8 weeks, 2 sessions per week, Aerobic training will be provided as treadmill walking. It will be performed either downhill or on a flat treadmill, depending on the group. Warm-up and stretching exercises Resistance exercises will be performed with a load equivalent to 50% of 1 maximum repetition. 10 repetitions will be performed in sets, one set in each session. Based on the differences in the general condition of the patients, different workloads and modifications will be used when creating an exercise program for each patient. Resistance exercises will focus on both upper and lower extremity muscles.
Treadmill exercise will be applied for 30 minutes in the target heart rate range of 60-80% intensity.
The target heart rate method will be used to determine the exercise intensity.
Blood pressure, heart rate and Borg Perceived Exertion Scale scores will be monitored during the exercises.
Traditional walking training will initially involve walking with a neutral incline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6 Minutes Walking Distance (6MWD)
Time Frame: Baseline and the end of the 8 weeks exercise program
|
6 MWD means the distance the patient walked in 6 minute walk test.
Its unit is meters.
|
Baseline and the end of the 8 weeks exercise program
|
|
Saint George Quality of life questionnaire
Time Frame: Baseline and the end of the 8 weeks exercise program
|
The St. George's Respiratory Questionnaire (SGRQ) is designed to measure quality of life.
Four scores are calculated Symptoms, Activity, Impacts, and Total.
Saint George Respiratory Questionaire (SGRQ) score: The SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life).
|
Baseline and the end of the 8 weeks exercise program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spirometric measurements (Forced vital capacity)
Time Frame: Baseline and the end of the 8 weeks exercise program
|
It is used to evaluate respiratory functions.
It is evaluated with a spirometer.
Forced vital capacity (FVC): the maximum amount of air that can be forcibly exhaled from the lungs after fully inhaling.
It can be recorded in percentages or liters.
|
Baseline and the end of the 8 weeks exercise program
|
|
Spirometric measurements (First second forced expiratory volume)
Time Frame: Baseline and the end of the 8 weeks exercise program
|
It is used to evaluate respiratory functions.
It is evaluated with a spirometer.
First-second forced expiratory volume (FEV1): the amount of air that can be exhaled with force in 1 second.
It can be recorded in percentages or liters.
|
Baseline and the end of the 8 weeks exercise program
|
|
Spirometric measurements (FEV1/FVC ratio)
Time Frame: Baseline and the end of the 8 weeks exercise program
|
It is used to evaluate respiratory functions.
It is evaluated with a spirometer.
It is calculated by dividing FEV1 by FVC.
It is expressed as a percentage.
|
Baseline and the end of the 8 weeks exercise program
|
|
Peripheral muscle strength
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Peripheral muscle strength will be assessed using a digital dynamometer.
Quadriceps femoris muscle strength; will be measured by applying maximum resistance 2-3 cm above the ankle malleolus of the patients in a sitting position using an digital dynamometer.
|
Baseline and the end of the 8 weeks exercise program
|
|
Hand grip strength
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Hand grip strength will be assessed in a sitting position.
During the test, the arm will be measured next to the body, with the shoulder adducted, the elbows flexed at 90°, the forearm and wrist in a neutral position, and patients will be asked to grip and release the dynamometer as strongly as possible, and the measurement will be repeated 3 times on both dominant and non-dominant extremities and the averages will be recorded.
A one-minute rest will be given between each trial.
|
Baseline and the end of the 8 weeks exercise program
|
|
Modified Medical Research Council Dyspnea Score
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Modified Medical Council Dyspnea score will rate the sensation of dyspnea as the person perceives it.The severity of dyspnea is rated on a scale of 0 to 4."0 point" means no dyspnea perception and "4point" means severe dyspnea perception.
|
Baseline and the end of the 8 weeks exercise program
|
|
Fatigue severity scale
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Fatigue levels of individuals will be assessed with the Fatigue Severity Scale (FSS).
The FSS consists of 9 questions scored using a 7-point Likert scale, indicating a perception of fatigue that may require medical intervention.
|
Baseline and the end of the 8 weeks exercise program
|
|
Hospital anxiety depression scale (HADS)
Time Frame: Baseline and the end of the 8 weeks exercise program
|
A scale consisting of 14 items developed by Zigmond and Snaith.
Seven of these items evaluate anxiety symptoms and seven evaluate depression symptoms.
The items in the scale are evaluated with a 4-point Likert scale and are based on a scoring system between 0-3.
|
Baseline and the end of the 8 weeks exercise program
|
|
Determination of blood lactate level
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Blood lactate level will be measured by fingertip sample using a portable lactate meter after a standardized exercise protocol applied before and after the intervention.
Blood samples will be recorded in mmol/L after being analyzed by the device.
|
Baseline and the end of the 8 weeks exercise program
|
|
Carbon monoxide diffusion capacity
Time Frame: Baseline and the end of the 8 weeks exercise program
|
Carbon monoxide diffusion capacity (DLCO) is the measurement of the passage of carbon monoxide gas in inspired air into the lung capillary blood.
Diffusion test is performed in the pulmonary function test laboratory.
|
Baseline and the end of the 8 weeks exercise program
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Eccentric_IPF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Pulmonary Fibrosis (IPF)
-
First Affiliated Hospital of Wenzhou Medical UniversityNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)
-
Mannkind CorporationRecruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingIdiopathic Pulmonary Fibrosis(IPF)
-
Avalyn Pharma Inc.RecruitingIdiopathic Pulmonary Fibrosis (IPF)Canada, Australia
-
Hubei Bio-Pharmaceutical Industrial Technological...Not yet recruiting
-
Beijing Tide Pharmaceutical Co., LtdChina-Japan Friendship HospitalRecruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
Dragonboat Biopharmaceutical Company LimitedRecruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
Regend TherapeuticsNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)China
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingIdiopathic Pulmonary Fibrosis (IPF)
-
Huan YeNot yet recruitingIdiopathic Pulmonary Fibrosis (IPF)China
Clinical Trials on Pulmonary Rehabilitation
-
Faculty of Medicine, SousseCompletedChronic Obstructive Pulmonary DiseaseTunisia
-
Universidade Federal de Santa MariaCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Istanbul Medipol University HospitalRecruitingLung Diseases | Bronchiectasis | Lung Diseases, Interstitial | Pulmonary RehabilitationTurkey
-
Beijing Chao Yang HospitalBeijing Municipal Health CommissionNot yet recruiting
-
Aveiro UniversityCentro Hospitalar do Baixo VougaRecruitingChronic Obstructive Pulmonary Disease | Interstitial Lung DiseasePortugal
-
National Cheng-Kung University HospitalCompletedTelerehabilitation | Pulmonary Rehabilitation | Compliance, Patient | COPD | Cardiopulmonary Exercise TestTaiwan
-
The Children's Hospital of Zhejiang University...Not yet recruiting
-
ADIR AssociationEuropean Union; Hopital La Musse; Groupe Hospitalier du Havre; Centre Hospitalier... and other collaboratorsRecruitingChronic Obstructive Pulmonary Disease (COPD)France
-
La Trobe UniversityMonash University; The Alfred; Austin HealthCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
University of EdinburghNot yet recruitingChronic Respiratory ConditionsCameroon, Nigeria, South Africa